Murat Tuncel
Overview
Explore the profile of Murat Tuncel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yilmaz Y, Ozercan M, Ancin B, Dikmen Z, Caglar Tuncali M, Tuncel M, et al.
Biomark Med
. 2025 Mar;
:187-194.
PMID: 40083263
Aim: To investigate the relationship between serum human epididymis protein 4 (HE4) levels and metabolic parameters of positron emission tomography (PET) imaging in patients with lung cancer. Methods: Sixty non-small...
2.
Hoffmann M, Soydal C, Virgolini I, Tuncel M, Kairemo K, Kapp D, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075689
Background And Objectives: For patients with prostate cancer (PCa), PSMA PET better diagnose metastases than conventional imaging. In a systematic review and meta-analysis (INPLASY register, 2024311004), we aimed to summarize...
3.
Tuncel M, Turkan C, Eryilmaz Y, Pala A, Kilickap S
Eur J Nucl Med Mol Imaging
. 2025 Jan;
PMID: 39865179
No abstract available.
4.
Petranovic Ovcaricek P, Tuncel M, Aghaee A, Campenni A, Giovanella L
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685478
Since the 1940s, 131-I radioiodine therapy (RIT) has been the primary treatment for metastatic differentiated thyroid cancer (DTC). Approximately half of these patients respond favorably to RIT, achieving partial or...
5.
Petranovic Ovcaricek P, de Keizer B, Campenni A, Kreissl M, Deandreis D, Tuncel M, et al.
Eur J Nucl Med Mol Imaging
. 2024 Nov;
52(2):380-385.
PMID: 39560781
No abstract available.
6.
Akyildiz A, Ismayilov R, Abdurrahimli N, Ormanci A, Guven D, Tuncel M, et al.
Jpn J Clin Oncol
. 2024 Oct;
55(2):100-105.
PMID: 39385508
Background: Trastuzumab emtansine (T-DM1) is a novel therapy for human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer, combining the targeted action of trastuzumab with the cytotoxic effects of...
7.
Kaya G, Akin S, Tuncel M, Kiratli P
Clin Nucl Med
. 2024 Apr;
49(6):559-560.
PMID: 38557413
A 56-year-old man with thoracal mass suspected of solitary plasmacytoma was referred for 18 F-FDG PET-CT scan. His PET-CT revealed FDG-avid rib mass and cervical lesion at level 2. He...
8.
Giovanella L, Tuncel M, Aghaee A, Campenni A, De Virgilio A, Petranovic Ovcaricek P
Semin Nucl Med
. 2024 Mar;
54(4):470-487.
PMID: 38503602
Molecular imaging is pivotal in evaluating and managing patients with different thyroid cancer histotypes. The existing, pathology-based, risk stratification systems can be usefully refined, by incorporating tumor-specific molecular and molecular...
9.
Giovanella L, Campenni A, Tuncel M, Petranovic Ovcaricek P
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254799
Thyroid nodules are common findings, particularly in iodine-deficient regions. Our paper aims to revise different diagnostic tools available in clinical thyroidology and propose their rational integration. We will elaborate on...
10.
Kreissl M, Petranovic Ovcaricek P, Campenni A, Vrachimis A, Tuncel M, Giovanella L
Eur J Nucl Med Mol Imaging
. 2024 Jan;
51(6):1678-1681.
PMID: 38226985
No abstract available.